Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Grant monitored from grants-gov.
- Buyer / agency
- National Institutes of Health
- Notice type
- Grant
- Solicitation number
- PAR-27-053
- Posted
- August 31, 2026
- Response deadline
- June 16, 2028
- Location
- US
- Estimated value
- Not published by the source
- NAICS
- Not supplied
- Source
- grants-gov
Summary
This notice of funding opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying substance use disorders (SUD), including fundamental circuitry and behavior relevant to substance use. For projects not requiring a phased research approach, applicants are encouraged to apply under a different funding activi…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.